Molecular imaging: game changing insights

The value of preclinical imaging

Starting imaging: Easier than you might think

In this whitepaper you will learn:

  • The value of imaging in preclinical research
  • The impact and benefits of preclinical imaging in the field of oncology, neurology, drug discovery and development
  • A practical guide on how to insource preclinical imaging

4 reasons to start with preclinical imaging

  1. An ethical and animal friendly research approach
  2. A holistic in vivo view on anatomical and molecular processes
  3. Increased statistical power for your preclinical study
  4. Valuable insights for a broad range of application fields
Read Blog article

State-of-the-art modular bench-top solutions from MOLECUBES make molecular imaging more accessible for a wider community of researchers in the field of preclinical drug discovery and development, fundamental and translational research. The CUBE platform enables you to retrieve integrated in vivo information that cannot be derived from other individual techniques requiring samples.

At MOLECUBES, we believe that molecular imaging should be accessible to every research lab. MOLECUBES has therefore made it its mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions with the highest performance, supported by fast and simple workflows.

What makes MOLECUBES stand out?

Request a demo / contact with sales

Worldwide dedication

Our team, with its roots in scientific research, combines more than 20 years of experience in hardware and software development. MOLECUBES is well aware of the many challenges faced by researchers and focuses on a fluent and user-friendly workflow that puts high quality output, increased throughput and ease of use at its center.

Niek Van Overberghe
Katarzyna Desrocques
Loïc Vervaeke
Nas Imus
Xin Chen
Robin Durand
The features we appreciate most are the wide range of applications that can be covered, along with a great simplicity of use, beautiful images and accessibility.
— George Loudos, founder and CEO BIOEMTECH, Greece